These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 35777919)

  • 21. Exploring the Antibacterial Activity and Cellular Fates of Enterobactin-Drug Conjugates That Target Gram-Negative Bacterial Pathogens.
    Guo C; Nolan EM
    Acc Chem Res; 2024 Apr; 57(7):1046-1056. PubMed ID: 38483177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacterial Iron Uptake Pathways: Gates for the Import of Bactericide Compounds.
    Schalk IJ; Mislin GLA
    J Med Chem; 2017 Jun; 60(11):4573-4576. PubMed ID: 28453272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Siderophore-drug complexes: potential medicinal applications of the 'Trojan horse' strategy.
    Górska A; Sloderbach A; Marszałł MP
    Trends Pharmacol Sci; 2014 Sep; 35(9):442-9. PubMed ID: 25108321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Siderophores promote cooperative interspecies and intraspecies cross-protection against antibiotics in vitro.
    Galdino ACM; Vaillancourt M; Celedonio D; Huse K; Doi Y; Lee JS; Jorth P
    Nat Microbiol; 2024 Mar; 9(3):631-646. PubMed ID: 38409256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The evolution of iron chelators for the treatment of iron overload disease and cancer.
    Kalinowski DS; Richardson DR
    Pharmacol Rev; 2005 Dec; 57(4):547-83. PubMed ID: 16382108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Siderophores as molecular tools in medical and environmental applications.
    Kurth C; Kage H; Nett M
    Org Biomol Chem; 2016 Sep; 14(35):8212-27. PubMed ID: 27492756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An overview of recent progress in siderophore-antibiotic conjugates.
    Kong H; Cheng W; Wei H; Yuan Y; Yang Z; Zhang X
    Eur J Med Chem; 2019 Nov; 182():111615. PubMed ID: 31434038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
    Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
    Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Siderophores: From natural roles to potential applications.
    Albelda-Berenguer M; Monachon M; Joseph E
    Adv Appl Microbiol; 2019; 106():193-225. PubMed ID: 30798803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Siderophores: Chemical tools for precise antibiotic delivery.
    Rodríguez D; González-Bello C
    Bioorg Med Chem Lett; 2023 May; 87():129282. PubMed ID: 37031730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and Syntheses of New Antibiotics Inspired by Nature's Quest for Iron in an Oxidative Climate.
    Miller MJ; Liu R
    Acc Chem Res; 2021 Apr; 54(7):1646-1661. PubMed ID: 33684288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cefiderocol: a novel siderophore cephalosporin.
    Choi JJ; McCarthy MW
    Expert Opin Investig Drugs; 2018 Feb; 27(2):193-197. PubMed ID: 29318906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental Methods for Evaluating the Bacterial Uptake of Trojan Horse Antibacterials.
    Southwell JW; Black CM; Duhme-Klair AK
    ChemMedChem; 2021 Apr; 16(7):1063-1076. PubMed ID: 33238066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemistry and Biology of Siderophores from Marine Microbes.
    Chen J; Guo Y; Lu Y; Wang B; Sun J; Zhang H; Wang H
    Mar Drugs; 2019 Sep; 17(10):. PubMed ID: 31569555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthetic sideromycins (skepticism and optimism): selective generation of either broad or narrow spectrum Gram-negative antibiotics.
    Lin YM; Ghosh M; Miller PA; Möllmann U; Miller MJ
    Biometals; 2019 Jun; 32(3):425-451. PubMed ID: 30919118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Building a Trojan Horse: Siderophore-Drug Conjugates for the Treatment of Infectious Diseases.
    Gumienna-Kontecka E; Carver PL
    Met Ions Life Sci; 2019 Jan; 19():. PubMed ID: 30855108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, nature and utility of universal iron chelator - Siderophore: A review.
    Khan A; Singh P; Srivastava A
    Microbiol Res; 2018; 212-213():103-111. PubMed ID: 29103733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conjugation to Native and Nonnative Triscatecholate Siderophores Enhances Delivery and Antibacterial Activity of a β-Lactam to Gram-Negative Bacterial Pathogens.
    Motz RN; Guo C; Sargun A; Walker GT; Sassone-Corsi M; Raffatellu M; Nolan EM
    J Am Chem Soc; 2024 Mar; 146(11):7708-7722. PubMed ID: 38457782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Siderophore-dependent iron uptake systems as gates for antibiotic Trojan horse strategies against Pseudomonas aeruginosa.
    Mislin GL; Schalk IJ
    Metallomics; 2014 Mar; 6(3):408-20. PubMed ID: 24481292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Siderophore-based iron acquisition and pathogen control.
    Miethke M; Marahiel MA
    Microbiol Mol Biol Rev; 2007 Sep; 71(3):413-51. PubMed ID: 17804665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.